大湄公河地区儿童脑炎(东南亚脑炎项目):一项多中心前瞻性研究
该多中心前瞻性研究在大湄公河地区4家转诊医院纳入664例儿童脑炎患者,64%明确了病因,其中日本脑炎病毒最常见(33%),18%为可治疗疾病,42%为疫苗可预防疾病;出院时23%有严重神经系统后遗症、13%死亡;1年随访时5%死亡、30%有神经系统后遗症、65%完全康复。
要点
- 664例儿童脑炎中64%明确病因,日本脑炎病毒占33%,为最常见病因。
- 18%为可治疗疾病,42%为疫苗可预防疾病。
- 出院时23%有严重神经系统后遗症,13%死亡;1年随访时65%完全康复。
核心结论
- 东南亚儿童脑炎多数病因可预防或可治疗,日本脑炎病毒为最常见病因,研究信息可指导大湄公河地区公共卫生政策以改进诊断、疫苗接种和早期治疗指南。
研究设计与样本
- 多中心、观察性、前瞻性研究,在柬埔寨、越南、老挝和缅甸4家转诊医院招募28日至16岁儿童脑炎患者。
- 纳入标准为意识状态改变持续超过24小时,并具备以下次要标准中的两项:发热(就诊前或后72小时内)、一次或多次全面性或部分性癫痫发作(排除热性癫痫发作)、新发局灶性神经功能缺损、脑脊液白细胞计数≥5个/mL、或脑影像(CT或MRI)提示脑炎病变。
- 全面诊断程序在各中心统一,一线检测在纳入时采样并在纳入后24小时内出结果以覆盖主要可治疗病因,二线检测随后进行以覆盖多数不可治疗病因。
- 独立专家医疗小组审查病历并对所有纳入儿童的病因进行归因。
- 采用多变量分析评估与出院时不良结局(严重神经系统后遗症和死亡)相关的危险因素,数据来自基线和纳入后第2天。
主要发现
- 2014年7月28日至2017年12月31日共纳入664例脑炎儿童,中位年龄4.3岁(1.8-8.8),女性295例(44%),男性369例(56%)。
- 425例(64%)确定了确诊或可能病因:216例(33%)为日本脑炎病毒,27例(4%)为登革病毒,26例(4%)为流感病毒,24例(4%)为单纯疱疹病毒1型,18例(3%)为结核分枝杆菌,17例(3%)为肺炎链球菌,17例(3%)为肠道病毒A71,74例(9%)为其他病原体,6例(1%)为自身免疫性脑炎。
- 83例(13%)在入院24小时内做出诊断;119例(18%)患有可治疗疾病,276例(42%)患有疫苗可预防疾病。
- 出院时153例(23%)有严重神经系统后遗症,83例(13%)死亡。
- 多变量分析中,不良结局的危险因素包括:入院时诊断为结核分枝杆菌感染(比值比3.23 [95%CI 1.04-10.03])、第2天昏迷(2.90 [1.78-4.72])、需要补充氧气(1.89 [1.25-2.86])、症状出现至入院时间超过1周(3.03 [1.68-5.48])。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Encephalitis is a worldwide public health issue, with a substantially high burden among children in southeast Asia. We aimed to determine the causes of encephalitis in children admitted to hospitals across the Greater Mekong region by implementing a comprehensive state-of-the-art diagnostic procedure harmonised across all centres, and identifying clinical characteristics related to patients' conditions. METHODS: In this multicentre, observational, prospective study of childhood encephalitis, four referral hospitals in Cambodia, Vietnam, Laos, and Myanmar recruited children (aged 28 days to 16 years) who presented with altered mental status lasting more than 24 h and two of the following minor criteria: fever (within the 72 h before or after presentation), one or more generalised or partial seizures (excluding febrile seizures), a new-onset focal neurological deficit, cerebrospinal fluid (CSF) white blood cell count of 5 per mL or higher, or brain imaging (CT or MRI) suggestive of lesions of encephalitis. Comprehensive diagnostic procedures were harmonised across all centres, with first-line testing was done on samples taken at inclusion and results delivered within 24 h of inclusion for main treatable causes of disease and second-line testing was done thereafter for mostly non-treatable causes. An independent expert medical panel reviewed the charts and attribution of causes of all the included children. Using multivariate analyses, we assessed risk factors associated with unfavourable outcomes (ie, severe neurological sequelae and death) at discharge using data from baseline and day 2 after inclusion. This study is registered with ClinicalTrials.gov, NCT04089436, and is now complete. FINDINGS: Between July 28, 2014, and Dec 31, 2017, 664 children with encephalitis were enrolled. Median age was 4·3 years (1·8-8·8), 295 (44%) children were female, and 369 (56%) were male. A confirmed or probable cause of encephalitis was identified in 425 (64%) patients: 216 (33%) of 664 cases were due to Japanese encephalitis virus, 27 (4%) were due to dengue virus, 26 (4%) were due to influenza virus, 24 (4%) were due to herpes simplex virus 1, 18 (3%) were due to Mycobacterium tuberculosis, 17 (3%) were due to Streptococcus pneumoniae, 17 (3%) were due to enterovirus A71, 74 (9%) were due to other pathogens, and six (1%) were due to autoimmune encephalitis. Diagnosis was made within 24 h of admission to hospital for 83 (13%) of 664 children. 119 (18%) children had treatable conditions and 276 (42%) had conditions that could have been preventable by vaccination. At time of discharge, 153 (23%) of 664 children had severe neurological sequelae and 83 (13%) had died. In multivariate analyses, risk factors for unfavourable outcome were diagnosis of M tuberculosis infection upon admission (odds ratio 3·23 [95% CI 1·04-10·03]), coma on day 2 (2·90 [1·78-4·72]), supplementary oxygen requirement (1·89 [1·25-2·86]), and more than 1 week duration between symptom onset and admission to hospital (3·03 [1·68-5·48]). At 1 year after inclusion, of 432 children who were discharged alive from hospital with follow-up data, 24 (5%) had died, 129 (30%) had neurological sequelae, and 279 (65%) had completely recovered. INTERPRETATION: In southeast Asia, most causes of childhood encephalitis are either preventable or treatable, with Japanese encephalitis virus being the most common cause. We provide crucial information that could guide public health policy to improve diagnostic, vaccination, and early therapeutic guidelines on childhood encephalitis in the Greater Mekong region. FUNDING: Institut Pasteur, Institut Pasteur International Network, Fondation Merieux, Aviesan Sud, INSERM, Wellcome Trust, Institut de Recherche pour le Développement (IRD), and Fondation Total.
引用
- Pommier JD, Gorman C, Crabol Y, et al. Childhood encephalitis in the Greater Mekong region (the SouthEast Asia Encephalitis Project): a multicentre prospective study. Lancet Glob Health. 2022. PMID: 35714649. doi:10.1016/S2214-109X(22)00174-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。